Liu describes new CRISPR tech, co-founds company to develop it

The latest gene editing technology to emerge from the lab of base editing pioneer David Liu can correct disease-causing mutations without making double-stranded DNA breaks, and without relying on a cell's natural DNA damage repair processes -- features that could translate to fewer off-target edits and higher efficiency repairs than other editing tools.

A new company called Prime Medicine was formed around the technology, but few details about how the company plans to put it to use have been disclosed...